Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGDR2 | Q9Y5Y4 | 15/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | CASP3 | P42574 | 1/20 | 0.40 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.40 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.40 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | RGS12 | O14924 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | PKM | P14618 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3597738 | 0.88 | ALDH1A1 (0.40) | PTGDR2ALDH1A1CYP1A2CYP2C9CYP2C19 | |
| SCHEMBL3612786 | 0.87 | ALDH1A1 (0.39) | PTGDR2ALDH1A1CYP1A2CYP2C9CYP2C19 | |
| SCHEMBL3613236 | 0.87 | KDM4E (0.54) | PTGDR2ALDH1A1CYP1A2CYP2C9CYP2C19 | |
| SCHEMBL3615067 | 0.85 | ALDH1A1 (0.38) | PTGDR2ALDH1A1CYP1A2CYP2C9CYP2C19 | |
| SCHEMBL3604425 | 0.84 | KDM4E (0.43) | PTGDR2ALDH1A1CYP1A2CYP2C9CYP2C19 | |
| SCHEMBL3611526 | 0.84 | ALDH1A1 (0.39) | PTGDR2ALDH1A1CYP1A2CYP2C9CYP2C19 | |
| SCHEMBL3607401 | 0.83 | ALDH1A1 (0.42) | PTGDR2ALDH1A1CYP1A2CYP2C9CYP2C19 | |
| SCHEMBL3607405 | 0.83 | ALDH1A1 (0.42) | PTGDR2ALDH1A1CYP1A2CYP2C9CYP2C19 | |
| SCHEMBL3607959 | 0.82 | GAA (0.38) | PTGDR2ALDH1A1CYP1A2CYP2C9CYP2C19 | |
| SCHEMBL3612420 | 0.82 | SMN1; SMN2 (0.53) | ALDH1A1CYP1A2CYP2C9CYP2C19KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100016396-A1 | PYRAZOLE COMPOUND | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2010-01-21 | — | — | US | disclosed |
| EP-2128138-A1 | PYRAZOLE COMPOUND | Takeda Pharmaceutical Company Limited (JP) | 2009-12-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100016396-A1 | PYRAZOLE COMPOUND | SLC5A1, SLC5A2, GLP1R | PTGDR2 2422/4885ALDH1A1 365/4885CYP1A2 137/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.